Top Abstract Purchase Related
Home
>
Node
>
Subnode

Mass spectrometry in drug discovery: a current review

Feng, W.Yong.

Current Drug Discovery Technologies 1(4): 295-312

2004

ISSN/ISBN: 1570-1638
PMID: 16472245
Document Number: 574950
Drug discovery in the pharmaceutical industry has shown great demands for screening absorption, distribution, metabolism, excretion (ADME) and pharmacokinetics (PK) in guiding the selection of lead candidate compounds. Determination of ADME/PK properties of new chemical entities (NCE) in early drug discovery should allow defects to be corrected prior to time-consuming and expensive preclinical and clinical development stages. Mass spectrometry has evolved to become an irreplaceable technology in all types of drug discovery applications because of its high sensitivity, speed, selectivity, versatility, and ease of automation. This review will include current mass spectrometric techniques and applications in drug discovery, as well as future prospects.

Document emailed within 1 workday
Secure & encrypted payments

Hofstadler, S.A.; Griffey, R.H. 2000: Mass spectrometry as a drug discovery platform against RNA targets Current Opinion in Drug Discovery and Development 3(4): 423-431
Masucci, J.J.A.; Caldwell, G.G.W.; Jones, W.W.J.; Juzwin, S.S.J.; Sasso, P.P.J.; Evangelisto, M. 2001: The use of on-line and off-line chromatographic extraction techniques coupled with mass spectrometry for support of in vivo and in vitro assays in drug discovery Current Topics in Medicinal Chemistry 1(5): 463-471
Han, L.-S.; Ye, J.; Qiu, W.-J.; Gao, X.-L.; Wang, Y.; Jin, J.; Gu, X.-F. 2008: Diagnosis of inborn errors of metabolism using tandem mass spectrometry and gas chromatography mass spectrometry Zhonghua Yi Xue Za Zhi 88(30): 2122-2126
Yamaguchi, S. 2013: Clinical application of mass spectrometry in the pediatric field: current topics Rinsho Byori. Japanese Journal of Clinical Pathology 61(9): 817-825
Kojima, H.; Okabe, T.; Nagano, T. 2013: Open innovation center for drug discovery: a research-supporting network for drug discovery Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 141(6): 327-332
Gupta, A.K. 2018: Current Advances in Computational Approaches for Drug Discovery- Part II Current Topics in Medicinal Chemistry 18(27): 2267
Fujita, Y. 2013: Innovation by TaNeDS (Take a New challenge of Drug diScovery) collaborative drug discovery project Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 142(2): 89-95
Sherma, J. 2004: Inductively coupled plasma-optical emission spectrometry and -mass spectrometry Journal - Association of Official Analytical Chemists 87(2): 56a-62a
Fernández-Metzler, C.L.; Owens, K.G.; Baillie, T.A.; King, R.C. 1999: Rapid liquid chromatography with tandem mass spectrometry-based screening procedures for studies on the biotransformation of drug candidates Drug Metabolism and Disposition: the Biological Fate of Chemicals 27(1): 32-40
Amanfu, R.K.; Saucerman, J.J. 2011: Cardiac models in drug discovery and development: a review Critical Reviews in Biomedical Engineering 39(5): 379-395
Mastrangelo, A.; Armitage, E.G.; García, A.; Barbas, C. 2014: Metabolomics as a tool for drug discovery and personalised medicine. A review Current Topics in Medicinal Chemistry 14(23): 2627-2636
Ferreira, V.F.; da Rocha, D.R.; Lima Araújo, Kátia.G.; Santos, W.C. 2008: Advances in drug discovery to assess cholinergic neurotransmission: a systematic review Current Drug Discovery Technologies 5(3): 236-249
Wang, C.-G.; Liu, Y.; Shi, J.-L.; Xiao, Y.; Shi, S.-N.; Hou, W.-H.; Wang, Z.-J. 2013: Mass spectrum characterization of five valepotriates by electrospray ionization tandem mass spectrometry Zhongguo Zhong Yao Za Zhi 38(4): 578-584
Durden, D.A.; Fernandes, G. 2010: Quantitation of fluoroquinolones in honey using tandem mass spectrometry (LC-MS/MS): nested validation with two mass spectrometers Journal - Association of Official Analytical Chemists 93(5): 1633-1655
Arnott, D.; Shabanowitz, J.; Hunt, D.F. 1993: Mass spectrometry of proteins and peptides: sensitive and accurate mass measurement and sequence analysis Clinical Chemistry 39(9): 2005-2010
Yamaguchi, J.; Ohmichi, M.; Hasegawa, M.; Yoshida, H.; Ogawa, N.; Higuchi, S. 2001: Identification of rat urinary and biliary metabolites of esonarimod, a novel antirheumatic drug, using liquid chromatography/electrospray ionization tandem mass spectrometry with postcolumn addition of 2-(2-methoxyethoxy)ethanol, a signal-enhancing modifier Drug Metabolism and Disposition: the Biological Fate of Chemicals 29(6): 806-812
Young, S.S. 1999: Discovery 99: accelerate and improve the drug discovery process. 26-29 April 1999, San Diego, CA, USA IDrugs: the investigational drugs journal 2(7): 648-649
Shen, Y. 2007: Discovery on Target 2007--CHI's Fifth Annual Conference. RNAi for Drug Discovery and Therapeutics IDrugs: the investigational drugs journal 10(12): 848-850
Gerina-Berzina, A.; Hasnere, S.; Kolesovs, A.; Umbrashko, S.; Muceniece, R.; Nakurte, I. 2017: Determination of cisplatin in human blood plasma and urine using liquid chromatography-mass spectrometry for oncological patients with a variety of fatty tissue mass for prediction of toxicity Experimental Oncology 39(2): 124-130
Sherma, J. 2004: Secondary ion mass spectrometry Journal - Association of Official Analytical Chemists 87(5): 142a-147a